(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

CYCARNEY

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

CYCARNEY

ST13

US500000079358455

Classe

1, 5, 30

Pedido

79358455

Registro

7410719

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

33

Atualização mais recente

03/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 30

Data de depósito

05/10/2022

Data de registro

11/06/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

11/06/2024

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

03

Localização do titular

JP

Examinador

CAYSIDO, REBECCA TOLENTINO

Unidade examinadora

N50

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Nagayoshi Pharmaceutical Company Ltd.

Representantes

George W. Lewis WHDA, LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 30

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Water-soluble polysaccharides that improve dyslipidemia for use in the manufacture of pharmaceuticals; water-soluble polysaccharides that improve glucose intolerance for use in the manufacture of pharmaceuticals; water-soluble polysaccharides that improve relaxation of intestinal peristalsis for use in the manufacture of pharmaceuticals; water-soluble polysaccharides with antihypertensive effect for use in the manufacture of pharmaceuticals; vitamins for use in the manufacture of food products; vitamins for use in the manufacture of pharmaceuticals; vitamins for use in the manufacture of cosmetics; chemicals consisting of minerals for food manufacturing; chemicals consisting of minerals for manufacturing pharmaceuticals; chemicals consisting of minerals for cosmetics manufacturing; inorganic salts for industrial purposes; protein in raw material form for industrial use; proteins for the food industry; proteins for use in manufacture; animal and vegetable albumin in raw material form for industrial purposes; albumin for industrial purposes; bacterial cultures for addition to food products; active chemical ingredients for use in the manufacture of pharmaceuticals for treating dyslipidemia; biological preparations for use in industry and scienceother than for medical or veterinary purposes; chemical preparations for scientific purposesother than for medical or veterinary use; plant extracts for the food industry; plant extracts for use in the manufacture of cosmetics; plant extracts for use in the manufacture of food; plant extracts for use in the manufacture of pharmaceuticals; probiotic bacteria for the food industry for use in food manufacture; higher fatty acids for industrial purposes; flour for industrial purposes and starch for industrial purposes

Classe 5

Water-soluble dietary fiber to aid digestion; dietary fiber for use as an ingredient in the manufacture of dietary supplements; vitamin preparations; mineral dietary supplements; protein dietary supplements; albumin dietary supplements; probiotic dietary supplements; candy for medical purposes; confectionery for medicinal purposes; nutritional supplements; dietary supplements for humans; pharmaceutical preparations for treating dyslipidemia; syrups for pharmaceutical purposes for the treatment of dyslipidemia; syrups for veterinary purposes for treatment of intestinal bacteria; syrups being medicines for the treatment of dyslipidemia; cough syrups; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages for babies adapted for medical use; liquid formula milk as beverages for babies; food for babies; lacteal flour for babies; capsules sold empty for pharmaceutical medicines

Classe 30

Tea; tea-based beverages; coffee; coffee-based beverages; cocoa; cocoa-based beverages; cookies; chips as cereal productscereal rice chips; cereal-based chips; confectionerycandy and chocolate; confectionery made of sugar; frozen confectionery; bread; buns; seasonings; golden syrup; table syrup; topping syrups; treacles; molasses syrup; maple syrup; yacon syrup; agave syrup for use as a natural sweetener; corn syrup for culinary purposes; starch syrup for culinary purposes; honey; ice cream mixes; cereal bars; cereal preparationsready-to-eat cerealscereal barscereal-based snackscereal cookies; chocolate-based spreads; meat tenderizers for household purposes; preparations for stiffening whipped cream being starch-based thickeners for whipped cream; yeast powder; yeast; baking powder; flour

Publicações

Histórico de despachos e eventos da marca no USPTO.

33 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

14/12/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

21/11/2024

FIMP

FINAL DISPOSITION PROCESSED

21/11/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/09/2024

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

30/06/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/06/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

11/06/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/06/2024

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

07/06/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

26/03/2024

PUBO

PUBLISHED FOR OPPOSITION

26/03/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/03/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/03/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

21/02/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

20/02/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

20/02/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

20/02/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/02/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

01/02/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/02/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/02/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/02/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/02/2024

RFNT

REFUSAL PROCESSED BY IB

13/09/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

20/08/2023

RFRR

REFUSAL PROCESSED BY MPU

20/08/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

21/07/2023

CNRT

NON-FINAL ACTION WRITTEN

20/07/2023

DOCK

ASSIGNED TO EXAMINER

20/07/2023

MAFR

APPLICATION FILING RECEIPT MAILED

03/01/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

29/12/2022

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

28/12/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

23/12/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace CYCARNEY ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.